Cargando…

The use of the Medication Event Monitoring System (MEMS) for assessing medication adherence for chronic conditions: use and results from a 12 month trial of patients in remission with ulcerative colitis (UC)

Detalles Bibliográficos
Autores principales:	Gillespie, David, Hood, Kerenza, Williams, Andrew, Stenson, Rachel, Probert, Christopher, Hawthorne, Antony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287705/ http://dx.doi.org/10.1186/1745-6215-12-S1-A130

Ejemplares similares

One-year Investigator-blind Randomized Multicenter Trial Comparing Asacol 2.4 g Once Daily with 800 mg Three Times Daily for Maintenance of Remission in Ulcerative Colitis
por: Hawthorne, A Barney, et al.
Publicado: (2012)

The use of randomisation-based efficacy estimators in non-inferiority trials
por: Gillespie, David, et al.
Publicado: (2015)

The use of randomisation-based efficacy estimators in non-inferiority trials
por: Gillespie, David, et al.
Publicado: (2017)

Reliability of the Endoscopic Ultrasound Ulcerative Colitis (EUS-UC) score for assessment of inflammation in patients with ulcerative colitis
por: Yan, Brian M., et al.
Publicado: (2021)

Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives
por: Awaad, Amani S., et al.
Publicado: (2017)

Prevalence of Intestinal Protozoan Infection in Patients with Ulcerative Colitis (UC) in Isfahan, Iran
por: Pestechian, Nader, et al.
Publicado: (2021)

Using a Deep Learning Model to Address Interobserver Variability in the Evaluation of Ulcerative Colitis (UC) Severity
por: Kim, Jeong-Heon, et al.
Publicado: (2023)

Infliximab-Induced Non-specific Interstitial Pneumonitis in a Patient With Ulcerative Colitis (UC)
por: Nasir, Syed Alishan, et al.
Publicado: (2022)

16. SCORE-UC: Antibiotic Stewardship in Urgent Care
por: Hersh, Adam, et al.
Publicado: (2020)

Data linkage can reduce the burden and increase the opportunities in the implementation of Value-Based Health Care policy: a study in patients with ulcerative colitis (PROUD-UC Study)
por: Walshe, John, et al.
Publicado: (2022)

OA07.03. Randomized, double-blind, double-dummy trial of myrrh, chamomile, coffee charcoal compared to mesalazine in maintaining remission in ulcerative colitis
por: Langhorst, J, et al.
Publicado: (2012)

Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis
por: Haga, Keiichi, et al.
Publicado: (2022)

Learning to mark: a qualitative study of the experiences and concerns of medical markers
por: Hawthorne, Kamila, et al.
Publicado: (2006)

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
por: Naganuma, Makoto, et al.
Publicado: (2021)

The Role of Syndrome Differentiation in the Clinical Efficacy of Punica Granatum on Patients with Ulcerative Colitis
por: Kamali, Mohammadali, et al.
Publicado: (2016)

Does feedback of medication execution using MEMS caps aid adherence to HAART?: the MEMRI study (MEMS as Realistic Intervention)
por: Davies, S, et al.
Publicado: (2010)

Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission
por: Głąbska, Dominika, et al.
Publicado: (2020)

Transcriptional Signatures That Define Ulcerative Colitis in Remission
por: Fenton, Christopher G, et al.
Publicado: (2020)

Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)
por: Jentzer, Alexandre, et al.
Publicado: (2020)

Involvement of Proinflammatory Arachidonic Acid (ARA) Derivatives in Crohn’s Disease (CD) and Ulcerative Colitis (UC)
por: Kikut, Justyna, et al.
Publicado: (2022)

Potential Biomarkers Associated with Differential Manifestations of Ulcerative Colitis (UC) in Uyghur and Han Population in China
por: Lu, Jia Jie, et al.
Publicado: (2021)

Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial
por: Sarbagili Shabat, Chen, et al.
Publicado: (2021)

Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diary
por: Higgins, Peter D. R., et al.
Publicado: (2018)

Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study
por: Maaser, Christian, et al.
Publicado: (2020)

Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound Index
por: Bots, Steven, et al.
Publicado: (2021)

Dose Escalation of Biologics in Biologic-Naïve Patients With Ulcerative Colitis: Outcomes From the ODESSA-UC Study
por: Ghosh, Sabyasachi, et al.
Publicado: (2023)

Adherence in ulcerative colitis: an overview
por: Testa, Anna, et al.
Publicado: (2017)

Remission of ulcerative colitis flare-up induced by nivolumab
por: Iwamoto, Maho, et al.
Publicado: (2020)

Therapy Used to Promote Disease Remission Targeting Gut Dysbiosis, in UC Patients with Active Disease
por: Mirsepasi-Lauridsen, Hengameh Chloè
Publicado: (2022)

Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database
por: Lachaine, Jean, et al.
Publicado: (2013)

A15 GENETIC OR DIET-ASSOCIATED DEFECTS IN MUCUS FACILITATE ULCERATIVE COLITIS PATHOBIONT-DRIVEN COLITIS
por: Yang, H, et al.
Publicado: (2023)

The variation characteristics of fecal microbiota in remission UC patients with anxiety and depression
por: Xu, Lingyun, et al.
Publicado: (2023)

Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire
por: Bueno-Hernández, Nallely, et al.
Publicado: (2015)

Ecological and network analyses identify four microbial species with potential significance for the diagnosis/treatment of ulcerative colitis (UC)
por: Li, Wendy, et al.
Publicado: (2021)

Medical Therapy of Active Ulcerative Colitis
por: Bürger, Martin, et al.
Publicado: (2015)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
por: Pop, Corina Silvia, et al.
Publicado: (2020)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
por: Chen, An-Yu, et al.
Publicado: (2019)

Real-life evaluation of histologic scores for Ulcerative Colitis in remission
por: Arkteg, Christian Børde, et al.
Publicado: (2021)

Analysis of Endoscopic Evaluation Reliability for Ulcerative Colitis in Histological Remission
por: Kanazawa, Mimari, et al.
Publicado: (2021)

Rasch analysis of the PedsQL 3.0 diabetes module
por: Pickles, Tim, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0djv8ilbad6ado3l373m69pib6